All are true about Cotrimoxazole, except
## Core Concept
Cotrimoxazole, also known as trimethoprim-sulfamethoxazole (TMP-SMX), is an antibiotic combination used to treat various bacterial infections. It works by inhibiting folic acid synthesis in bacteria, which is essential for their growth and replication. This combination targets different steps in the folic acid synthesis pathway.
## Why the Correct Answer is Right
The correct answer, although not directly provided, would relate to an exception or incorrect statement about cotrimoxazole. Generally, cotrimoxazole is known for its broad-spectrum activity, its use in treating opportunistic infections in HIV/AIDS patients (like Pneumocystis jirovecii pneumonia), and its effectiveness against certain types of diarrhea and urinary tract infections.
## Why Each Wrong Option is Incorrect
- **Option A:** Without specific details on option A, we can infer that any statement claiming cotrimoxazole is effective against a wide range of bacterial infections, its mechanism of action involves inhibiting dihydrofolate reductase and sulfonamide inhibiting dihydropteroate synthase, or its use in specific clinical scenarios (e.g., PCP prophylaxis in HIV) would be true.
- **Option B:** Similarly, if option B suggests cotrimoxazole has a synergistic effect by targeting two steps in the folic acid synthesis pathway, this would be a true statement, making it incorrect as an "except" choice.
- **Option C:** If option C mentions common side effects or resistance patterns, these would likely be accurate aspects of cotrimoxazole, making the statement incorrect if chosen as the "except."
- **Option D:** This option would be evaluated based on its accuracy regarding cotrimoxazole's pharmacology, clinical use, or side effects.
## Clinical Pearl / High-Yield Fact
A key point to remember is that cotrimoxazole can cause **hyperkalemia** as a side effect, particularly in patients with renal insufficiency or when used in conjunction with other medications that increase potassium levels. Additionally, it's crucial to note that **TMP-SMX can cause kernicterus in newborns** and is generally avoided in the first month of life due to the risk of kernicterus.
## Correct Answer: D.